GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$91.34 USD
+0.52 (0.57%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $91.35 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Price, Consensus and EPS Surprise
GEHC 91.34 +0.52(0.57%)
Will GEHC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for GEHC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GEHC
GE HealthCare's Shares Rise After the Launch of Versana Premier
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe
GEHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent
Other News for GEHC
GE HealthCare says major academic medical center adopts Hospital Pulse Tile
GE Healthcare Technologies Inc’s Flyrcado Gains Buy Rating Amid FDA Approval and Revenue Growth Potential
Ex-Dividend Reminder: GE HealthCare Technologies, Revvity and First Busey
IYH: Healthcare Dashboard For October
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'